Ronan J. Kelly

Also affiliated with University Hospital Galway, Baylor Scott & White Health

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses”.

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses

Nature Medicine(2024)10.1038/s41591-024-02877-z

N/A

2.2DataRank · unranked

113 citations

Blair V. Landon, Ali H. Zaidi, Dipika Singh, Jenna VanLiere Canzoniero, Archana Balan +26 more

Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-51271-3

N/A

0.654DataRank · unranked

17 citations

Kristen E. Lowder, Kevin S. Kapner, Ronan J. Kelly, Hui Zheng, Nadine J. McCleary +20 more

Data from A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

(2023)10.1158/1078-0432.c.6519969

N/A

0DataRank · unranked

0 citations

Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz +8 more

Data from A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

(2023)10.1158/1078-0432.c.6519969.v1

N/A

0DataRank · unranked

0 citations

Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz +8 more

Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy

Cancers(2024)10.3390/cancers16213644

N/A

0DataRank · unranked

9 citations

Seoho Lee, James R. White, Yujie Zhao, Jacqueline T. Ferri, Gavin Pereira +21 more

A novel gene signature for predicting response to chemoradiotherapy in esophageal adenocarcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.445

N/A

0DataRank · unranked

1 citations

Ashten N. Omstead, Blair A. Jobe, Rachael Kreft, Anastasia Gorbunova, Madison Salvitti +4 more

Longitudinal tumor-informed cfDNA whole genome sequencing to capture residual disease during neoadjuvant immune checkpoint inhibition in resectable gastroesophageal cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.2550

N/A

0DataRank · unranked

1 citations

Nisha Rao, Gavin Pereira, Noushin Niknafs, Mark Sausen, Ellen L. Verner +15 more

A novel circulating diagnostic and prognostic metagenomic signature in esophageal adenocarcinoma: Implications for precision oncology.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.336

N/A

0DataRank · unranked

0 citations

Ashten N. Omstead, John D. Gillece, Anastasia Gorbunova, Rachael Kreft, Sarah K. Highlander +6 more